After finishing at $12.50 in the prior trading day, Fusion Pharmaceuticals Inc (NASDAQ: FUSN) closed at $12.20, down -2.40%. In other words, the price has decreased by -$0.30 from its previous closing price. On the day, 1055912 shares were traded.
Ratios:
Our goal is to gain a better understanding of FUSN by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 11.63 and its Current Ratio is at 11.63. In the meantime, Its Debt-to-Equity ratio is 0.28 whereas as Long-Term Debt/Eq ratio is at 0.25.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Raymond James on December 27, 2023, Upgraded its rating to Strong Buy and sets its target price to $15 from $12 previously.
On September 29, 2023, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $13.
On June 23, 2023, Raymond James started tracking the stock assigning a Outperform rating and target price of $13.Raymond James initiated its Outperform rating on June 23, 2023, with a $13 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, FUSN now has a Market Capitalization of 883.35M and an Enterprise Value of 744.63M. For the stock, the TTM Price-to-Sale (P/S) ratio is 399.73 while its Price-to-Book (P/B) ratio in mrq is 4.48. Its current Enterprise Value per Revenue stands at 337.24 whereas that against EBITDA is -8.66.
Stock Price History:
Over the past 52 weeks, FUSN has reached a high of $13.99, while it has fallen to a 52-week low of $2.31. The 50-Day Moving Average of the stock is 9.84, while the 200-Day Moving Average is calculated to be 5.42.
Shares Statistics:
The stock has traded on average 1.18M shares per day over the past 3-months and 1.34M shares per day over the last 10 days, according to various share statistics. A total of 72.41M shares are outstanding, with a floating share count of 47.72M. Insiders hold about 34.09% of the company’s shares, while institutions hold 58.59% stake in the company. Shares short for FUSN as of Feb 15, 2024 were 6.8M with a Short Ratio of 5.74, compared to 3.2M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 9.39% and a Short% of Float of 10.04%.
Earnings Estimates
Its stock is currently analyzed by 12 different market analysts. On average, analysts expect EPS of -$0.33 for the current quarter, with a high estimate of -$0.27 and a low estimate of -$0.42, while EPS last year was -$0.55. The consensus estimate for the next quarter is -$0.34, with high estimates of -$0.19 and low estimates of -$0.4.
Analysts are recommending an EPS of between -$1.31 and -$1.78 for the fiscal current year, implying an average EPS of -$1.43. EPS for the following year is -$1.38, with 13 analysts recommending between -$0.82 and -$1.82.
